Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

World's First Zinc Ionophore Oral Spray Launches in the EU


MILAN, Aug. 1, 2020 /PRNewswire/ -- Dr ZinX has launched their Patent Pending Zinc + Hinokitiol Oral Spray across Amazon EU today. This is the first time a Zinc Ionophore oral spray combination has been available to the EU market.

"A combination of Zinc Salts and Hinokitiol can be applied as an inexpensive, effective and safe alternative approach to fight respiratory viruses." - Dr Nikola Kolundzic, Kings College London

Following wide publication and support from President Trump for the use of a Hydroxychloroquine + Zinc Combination, Zinc has come under increasing interest. Currently Hydroxychloroquine is only available through a prescription from a Doctor. This makes the launch of the Dr ZinX Oral Spray in the EU even more interesting given its status as a cosmetic, allowing doctors to issue it freely to patients, without need for a prescription.

Anti-Viral Role of Hinokitiol:

Hinokitol has been found to increase the cellular import of Zn2+ and to be effective in the combat with RNA viruses such as influenza virus, respiratory syncytial virus and picornaviruses. Hinokitiol is a tropolone compound with a seven-membered carbon ring and an isopropyl side chain. Zinc ion is of vital importance as a cofactor for various cellular processes and viral proteins. Metallothioneins regulate the intracellular concentration of free Zn2+. Intracellular Zn2+ concentration disrupts the replication cycle of certain RNA viruses. - MD MSci Marija Petkovic 

Role of Hinokitiol in Inflammation: 

Early evidence suggests that Hinokitiol has a role in dampening the immune response and preventing excessive inflammation. The culture of T lymphocytes generated from the spleen of mice resulted in reduced proliferation of lymphocytes and reduced expression of the inflammatory cytokine interferon gamma (IFN-?) which has a strong role in inflammatory diseases and autoimmunity. It has also shown that it up-regulates p21, a regulatory cell cycle inhibitor. The inhibition of this molecule results in malignant proliferation of T lymphocytes and autoimmunity. 

For Press Inquiries Contact: [email protected]

Related Files

Dr ZinX Infographic 2.jpg

Dr ZinX Patent Infographic.jpg

Related Images

dr-zinx-patent-pending.jpg
Dr ZinX Patent Pending
Dr ZinX Patent Pending Ingredient Combination: Zinc + Hinokitiol

Related Links

Dr ZinX Amazon Page

SOURCE Dr ZinX


These press releases may also interest you

at 06:30
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 06:15
CNFinance Holdings Limited ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:05
REX American Resources Corporation ("REX" or the "Company") , a leading ethanol production company, today announced financial and operational results for the Company's full year and fiscal fourth quarter 2023. REX American Resources' Q4 and full...

at 03:00
Caledonia Mining Corporation Plc ("Caledonia" or the "Company")  announces its operating and financial results for the year ended December 31, 2023 (the "Year"). Further information on the financial and operating results for the Year and the quarter...



News published on and distributed by: